Moxifloxacin and Zolpidem tartrate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Moxifloxacin (moxifloxacin) and Zolpidem tartrate (zolpidem tartrate). Common drug interactions include coccidioidomycosis among females and hypotension among males.

The phase IV clinical study analyzes what interactions people have when they take Moxifloxacin and Zolpidem tartrate. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Moxifloxacin?

Moxifloxacin has active ingredients of moxifloxacin. eHealthMe is studying from 12,980 Moxifloxacin users. Check the latest studies of Moxifloxacin.

What is Zolpidem tartrate?

Zolpidem tartrate has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 32,177 Zolpidem tartrate users. Check the latest studies of Zolpidem tartrate.



On Jul, 11, 2026

48 people who take Moxifloxacin and Zolpidem tartrate together, and have interactions are studied.

Moxifloxacin and Zolpidem tartrate drug interactions.

What are the common drug interactions of Moxifloxacin and Zolpidem Tartrate, by gender? *:

female:

  1. Coccidioidomycosis (serious disease of the lungs and other tissues, caused by the fungus coccidioides immitis)
  2. Colonoscopy
  3. Depression
  4. Disease progression
  5. Dyspnoea (difficult or laboured respiration)
  6. Emotional distress
  7. Erythema of eyelid (redness of the eyelid)
  8. Eye disorder
  9. Fall
  10. Feeling jittery

male:

  1. Hypotension (abnormally low blood pressure)
  2. Pneumonia
  3. Muscle atrophy (a decrease in the mass of the muscle)
  4. Osteoporosis (bones weak and more likely to break)
  5. Pain
  6. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  7. Tooth loss
  8. Bone loss
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the common drug interactions of Moxifloxacin and Zolpidem Tartrate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Osteonecrosis (death of bone)
  3. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
  4. Tuberculosis (a bacterial infection by mycobacterium tuberculosis)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Neuropathy peripheral (surface nerve damage)
  7. Electrocardiogram qt prolonged
  8. Electrocardiogram repolarisation abnormality
  9. Hypotension (abnormally low blood pressure)

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Back pain
  4. Blood creatinine increased
  5. Emotional distress
  6. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  7. Nephrolithiasis (calculi in the kidneys)
  8. Pain
  9. Renal impairment (severely reduced kidney function)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Bone loss
  5. Chondropathy (disease of the cartilage)
  6. Dry eye (lack of adequate tears)
  7. Emotional distress
  8. Eye irritation
  9. Gait disturbance
  10. Muscle atrophy (a decrease in the mass of the muscle)

60+:

  1. Pneumonia
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Septic shock (shock due to blood infection)
  4. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  5. Anaemia (lack of blood)
  6. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  7. Chronic kidney disease
  8. Death
  9. Haemoglobin decreased
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 9 people, 18.75%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 14.58%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 14.58%
  4. Hiv Infection: 5 people, 10.42%
  5. High Blood Pressure: 5 people, 10.42%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 10.42%
  7. Oedema (fluid collection in tissue): 4 people, 8.33%
  8. Multiple Myeloma (cancer of the plasma cells): 4 people, 8.33%
  9. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 8.33%
  10. High Blood Cholesterol: 4 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Moxifloxacin and Zolpidem tartrate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Moxifloxacin and Zolpidem tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Moxifloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zolpidem tartrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Moxifloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolpidem tartrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin and zolpidem tartrate (the active ingredients of Moxifloxacin and Zolpidem tartrate, respectively), and Moxifloxacin and Zolpidem tartrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: